Trial results for new lung cancer drug are ‘off the charts’, say doctors
Trial results for new lung cancer drug are ‘off the charts’, say doctors
www.theguardian.com Trial results for new lung cancer drug are ‘off the charts’, say doctors
More than half of patients with advanced forms of disease who took lorlatinib were still alive after five years with no progression
0 comments